Assets 更改
Acadia Pharmaceuticals USD 855.1M 106.15M 2024-03
ALKERMES USD 2.12B 12.33M 2024-03
Alnylam Pharmaceuticals USD 3.82B 5.49M 2024-03
Biogen USD 26.57B 277.2M 2024-03
BioMarin Pharmaceutical USD 6.87B 31.07M 2024-03
Bristol-Myers Squibb USD 99.03B 7.77B 2024-03
Corcept Therapeutics USD 655.94M 34.42M 2024-03
Cytokinetics USD 808.08M 16.23M 2024-03
Eisai JPY 1.31T 22.76B 2023-12
Eli Lilly USD 63.94B 6.03B 2024-03
Incyte USD 7.14B 353.5M 2024-03
Intra Cellular Therapies USD 747.04M 18.74M 2024-03
J&J USD 171.97B 5.9B 2024-03
Moderna USD 16.73B 1.7B 2024-03
Neurocrine Biosciences USD 3.47B 624.2M 2024-03
Pfizer USD 221.1B 6.07B 2024-03
Prothena USD 623.19M 73.19M 2024-03
PTC Therapeutics USD 1.79B 106.07M 2024-03
Sarepta Therapeutics USD 3.22B 114.68M 2024-03
Ultragenyx Pharmaceutical USD 1.31B 183.93M 2024-03
Vertex Pharmaceuticals USD 23.92B 2.19B 2024-03



Acadia Pharmaceuticals 资产 - 当前值,历史数据,预测,统计,图表和经济日历 - Jun 2024.